COVID-19Regulatory

Live updates: Trump notes ‘very sad milestone’ after U.S. coronavirus death toll surpasses 100,000

May 28, 2020 / By Antonia Noori FarzanKatie ShepherdJennifer HassanRick NoackMarisa IatiJohn WagnerMark BermanAdam TaylorBrittany Shammas and Felicia Sonmez

Four months after the first novel coronavirus infection was confirmed in the United States, the virus has claimed more than 100,000 lives here. It has killed people in every state. It has found victims in dense cities and rural towns. Some of the victims were well-known; many were unsung.

President Trump, who had remained uncharacteristically silent on the mounting death toll, noted the “very sad milestone” with a tweet on Thursday morning: “To all of the families & friends of those who have passed, I want to extend my heartfelt sympathy & love for everything that these great people stood for & represent. God be with you!”

The virus has killed more than 354,000 people worldwide, and some experts are now warning that it may never go away, even after a vaccine is developed. Embracing that reality is crucial to the next phase of America’s pandemic response.

“This virus is here to stay,” said Sarah Cobey, an epidemiologist and evolutionary biologist at the University of Chicago. “The question is, how do we live with it safely?”

READ THE REST HERE

Print Friendly, PDF & Email
Tags

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

Back to top button
Close